Feature | Synbiotics (n = 24) | Placebo (n = 19) | p value* |
---|---|---|---|
Overall health | Â | Â | 0.717 |
 Better | 1 (4%) | 1 (5%) |  |
 No effect | 23 (96%) | 17 (89%) |  |
 Worse | 0 (0%) | 1 (5%) |  |
Physical activity | Â | Â | 1 |
 More active | 2 (8%) | 2 (11%) |  |
 No effect | 22 (92%) | 17 (89%) |  |
 Less active | 0 (0%) | 0 (0%) |  |
Body weight | Â | Â | 0.217 |
 Improved | 0 (0%) | 2 (11%) |  |
 No effect | 23 (96%) | 15 (79%) |  |
 Worsened | 1 (4%) | 2 (11%) |  |
Appetite | Â | Â | 0.111 |
 Increased | 7 (29%) | 1 (5%) |  |
 No effect | 15 (63%) | 14 (74%) |  |
 Reduced | 2 (8%) | 4 (21%) |  |
Coat condition | Â | Â | 0.855 |
 Improved | 4 (17%) | 4 (21%) |  |
 No effect | 19 (79%) | 14 (74%) |  |
 Worsened | 1 (4%) | 1 (5%) |  |
Bristol stool score | 2.5 ± 0.9 | 3.0 ± 1.0 | 0.095 |
Defecation frequency | Â | Â | 0.405 |
 Increased | 5 (21%) | 1(5%) |  |
 No effect | 15 (63%) | 15 (79%) |  |
 Decreased | 4 (17%) | 3 (16%) |  |
Flatulence frequency | Â | Â | 0.529 |
 Increased | 1 (4%) | 1 (5%) |  |
 No effect | 22 (91%) | 15 (79%) |  |
 Decreased | 1 (4%) | 3 (16%) |  |
Diarrhea incidence | Â | Â | 0.078 |
 Yes | 0 (0%) | 3 (16%) |  |
 No | 24 (100%) | 16 (84%) |  |
Vomiting incidence | Â | Â | 0.306 |
 Yes | 1 (4%) | 3 (16%) |  |
 No | 23 (96%) | 16 (84%) |  |